mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone throughout the recurrent acquisition of CDKN2AIn the last many years, the amount of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped substantially,133 even so the course of action must be proposed to youthful/match individuals in